View in EDS HTML Full Text PDF Full Text

Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.

Saved in:
Bibliographic Details
Title: Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
Authors: Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Department of Oncology and Hematology-Oncology, University of Milano, Milano, Italy. paolo_tarantino@dfci.harvard.edu., Gupta H; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Hughes ME; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Files J; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Strauss S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kirkner G; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Feeney AM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li Y; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Garrido-Castro AC; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Barroso-Sousa R; Dasa Institute for Education and Research (IEPD), Brasilia, Brazil.; Dasa Oncology/Hospital Brasilia, Brasilia, Brazil., Bychkovsky BL; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., DiLascio S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sholl L; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., MacConaill L; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lindeman N; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Weill Cornell Medicine, New York, NY, USA., Johnson BE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Meyerson M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Jeselsohn R; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Qiu X; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li R; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Long H; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Winer EP; Yale Cancer Center, Yale School of Medicine, Smilow Cancer Hospital, New Haven, CT, USA., Dillon D; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Curigliano G; Division of Early Drug Development, European Institute of Oncology IRCCS, Milano, Italy., Cherniack AD; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Lin NU; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Source: Nature communications [Nat Commun] 2023 Dec 14; Vol. 14 (1), pp. 8321. Date of Electronic Publication: 2023 Dec 14.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38097580
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tarantino+P%22">Tarantino P</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.; Department of Oncology and Hematology-Oncology, University of Milano, Milano, Italy. paolo_tarantino@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Gupta+H%22">Gupta H</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+ME%22">Hughes ME</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Files+J%22">Files J</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Strauss+S%22">Strauss S</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kirkner+G%22">Kirkner G</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Feeney+AM%22">Feeney AM</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Garrido-Castro+AC%22">Garrido-Castro AC</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Barroso-Sousa+R%22">Barroso-Sousa R</searchLink>; Dasa Institute for Education and Research (IEPD), Brasilia, Brazil.; Dasa Oncology/Hospital Brasilia, Brasilia, Brazil.<br /><searchLink fieldCode="AU" term="%22Bychkovsky+BL%22">Bychkovsky BL</searchLink>; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22DiLascio+S%22">DiLascio S</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sholl+L%22">Sholl L</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22MacConaill+L%22">MacConaill L</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lindeman+N%22">Lindeman N</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+BE%22">Johnson BE</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Meyerson+M%22">Meyerson M</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jeselsohn+R%22">Jeselsohn R</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Qiu+X%22">Qiu X</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Li+R%22">Li R</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Long+H%22">Long H</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Winer+EP%22">Winer EP</searchLink>; Yale Cancer Center, Yale School of Medicine, Smilow Cancer Hospital, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Dillon+D%22">Dillon D</searchLink>; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Division of Early Drug Development, European Institute of Oncology IRCCS, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Cherniack+AD%22">Cherniack AD</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tolaney+SM%22">Tolaney SM</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+NU%22">Lin NU</searchLink>; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Dec 14; Vol. 14 (1), pp. 8321. <i>Date of Electronic Publication: </i>2023 Dec 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38097580
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-023-44124-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 8321
    Titles:
      – TitleFull: Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tarantino P
      – PersonEntity:
          Name:
            NameFull: Gupta H
      – PersonEntity:
          Name:
            NameFull: Hughes ME
      – PersonEntity:
          Name:
            NameFull: Files J
      – PersonEntity:
          Name:
            NameFull: Strauss S
      – PersonEntity:
          Name:
            NameFull: Kirkner G
      – PersonEntity:
          Name:
            NameFull: Feeney AM
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Garrido-Castro AC
      – PersonEntity:
          Name:
            NameFull: Barroso-Sousa R
      – PersonEntity:
          Name:
            NameFull: Bychkovsky BL
      – PersonEntity:
          Name:
            NameFull: DiLascio S
      – PersonEntity:
          Name:
            NameFull: Sholl L
      – PersonEntity:
          Name:
            NameFull: MacConaill L
      – PersonEntity:
          Name:
            NameFull: Lindeman N
      – PersonEntity:
          Name:
            NameFull: Johnson BE
      – PersonEntity:
          Name:
            NameFull: Meyerson M
      – PersonEntity:
          Name:
            NameFull: Jeselsohn R
      – PersonEntity:
          Name:
            NameFull: Qiu X
      – PersonEntity:
          Name:
            NameFull: Li R
      – PersonEntity:
          Name:
            NameFull: Long H
      – PersonEntity:
          Name:
            NameFull: Winer EP
      – PersonEntity:
          Name:
            NameFull: Dillon D
      – PersonEntity:
          Name:
            NameFull: Curigliano G
      – PersonEntity:
          Name:
            NameFull: Cherniack AD
      – PersonEntity:
          Name:
            NameFull: Tolaney SM
      – PersonEntity:
          Name:
            NameFull: Lin NU
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 12
              Text: 2023 Dec 14
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1